Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Mammary Tumor Surgery: Extent, Staging, and Pathology
The extent of mammary surgery depends on species, number and location of masses, tissue diagnosis, nodal questions, patient health, and reconstructive needs.
Read moreUrinary Tract Stenting for Tumor-Related Obstruction
A urinary stent may restore flow for selected tumor-related obstruction, but it is a palliative or enabling procedure rather than treatment of the underlying cancer.
Read moreFeeding Tube Placement During Cancer Treatment or Recovery
A feeding tube can provide measured nutrition, water, and selected medicines when safe voluntary intake is insufficient, with device choice matched to duration and anatomy.
Read moreImage-Guided Tumor Ablation and Embolization: Emerging Veterinary Options
Image-guided local procedures may be discussed at specialist centers for selected tumors, but indications, access, evidence, and follow-up remain technique- and diagnosis-specific.
Read moreElectrochemotherapy: Local Treatment With an Emerging Evidence Base
Electrochemotherapy combines electric pulses with a selected antineoplastic agent to increase local drug uptake and is available only in some veterinary settings.
Read more
Tyrosine Kinase Inhibitors: A Class-Level Monitoring Framework
Tyrosine kinase inhibitors are not one interchangeable drug class; target profile, label, evidence, dosing, monitoring, and adverse effects differ by product and patient.
Read moreImatinib in Canine Mast Cell Tumor Care: Extra-Label Evidence Review
Imatinib has published canine mast cell tumor experience but is not interchangeable with veterinary-labeled TKIs and requires specialist, legal, formulation, and evidence review.
Read moreNamed profile Masivet (Masitinib): EU/UK-Authorised Targeted Therapy for c-KIT-Mutated Canine Mast Cell TumorsRepresentative category illustration – no product packaging is shown.Masivet (Masitinib): EU/UK-Authorised Targeted Therapy for c-KIT-Mutated Canine Mast Cell Tumors
Masitinib is an oral canine TKI with an EMA veterinary authorization for a defined mast cell tumor setting; the current regional label governs eligibility and monitoring.
Read more
Named profile Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor TherapyRepresentative category illustration – no product packaging is shown.Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor Therapy
Stelfonta is an FDA-approved intratumoral treatment for narrowly defined canine mast cell tumors, with important current warnings about degranulation, wounds, pain, tissue loss, amputation, and death.
Read more
Prehabilitation Before Major Cancer Surgery
Prehabilitation prepares selected patients and households for surgery through safe conditioning, pain control, nutrition, equipment, and recovery planning without delaying urgent treatment.
Read moreRehabilitation After Limb Amputation
Post-amputation rehabilitation supports safe transfers, balance, remaining-limb loading, endurance, home access, and confidence after surgical clearance.
Read moreRange-of-Motion and Strengthening Exercises: Clearance Before Progression
Range-of-motion and strengthening exercises must match diagnosis, protected tissues, pain, healing phase, bone integrity, blood counts, and functional goals.
Read more